Continue reading this on our app for a better experience

Open in App
Floating Button
Home Capital Broker's Calls

Tech, healthcare acquisitions likely as Manulife US REIT explores growth: analysts

Jovi Ho
Jovi Ho • 4 min read
Tech, healthcare acquisitions likely as Manulife US REIT explores growth: analysts
Physical occupancy at MUST’s buildings averaged 32-34% for April and May, up from 25.3% in 1QFY2022. Photo: Manulife US REIT
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts remain positive on Manulife US REIT (MUST) following a dip in its portfolio occupancy in 1QFY2022, as the REIT explores inorganic growth opportunities this year.

MUST achieved a lower portfolio occupancy q-o-q at 91.6% at end-1QFY2022, compared to 92.3% at end-4QFY2021, due to lower occupancy at Figueroa, Peachtree, Exchange, Centerpointe and Capitol properties, partly offset by improved take-up at Michelson.

Physical occupancy at MUST’s buildings averaged 32-34% for April and May, up from 25.3% in 1QFY2022. Portfolio weighted average lease expiry stood at five years as at end-1QFY2022.

Balance sheet metrics remained stable q-o-q with gearing at 42.8% and interest cover of 3.4x.

In a May 9 note, CGS-CIMB Research analyst Lock Mun Yee is maintaining “add” on MUST with a lower target price of 86 US cents ($1.20), down from 89 US cents previously. The new target price represents a 43.3% upside.

“We keep our FY2022-2024 distribution per unit (DPU) estimates unchanged post update. However, we tweak down our target price due to a slightly higher cost of equity assumption of 7.84%, up from 7.58% previously. At a projected FY2022 dividend yield of 9.6%, much of the slower near-term growth has been priced in, in our view,” writes Lock.

See also: 'Slow and bumpy return to office' but physical occupancy at highest since pandemic: Manulife US REIT

In terms of capital management, MUST’s weighted all-in cost of funds stands at 2.86% as at end-1QFY2022. MUST has obtained refinancing commitment for US$207 million of debt maturing in FY2022.

With 86.5% of its debt in fixed rate loans, MUST indicated that for every 1% increase in funding cost, its DPU would decrease by 0.075 US cents.

“While its near-term focus is on improving leasing and portfolio occupancy, management will continue to explore inorganic growth opportunities and increasing its exposure in growth cities or tenants in growth sectors, including exploring portfolio optimisation strategies to enable capital recycling for growth,” says Lock.

See also: Can Manulife US REIT avoid buyer's remorse?

Tech, healthcare acquisitions likely

Meanwhile, UOB Kay Hian Research analysts Llelleythan Tan and Jonathan Koh have kept “buy” on MUST with an unchanged target price of 80 US cents, lower than that of CGS-CIMB.

With debt headroom of about US$360 million (at 50% gearing), Tan and Koh reckon MUST may add on acquisitions from emerging industries, such as tech and healthcare, as their next focus.

“Improving tenant sentiment was seen as new leases formed 54.0% of leases signed in 1QFY2022. MUST executed about 68,000 sq ft of leases in 1QFY2022, with strong positive rental reversion of +3.9%,” write Tan and Koh in a May 10 note.

Weighted average lease expiry (WALE) remained steady at 5.0 years, slightly down from 5.1 years in 4QFY2021, as 49.4% of leases by net lettable area (NLA) are expiring in 2027 and beyond.

Total expiring leases for 2022 by NLA softened to 6.2% from 8.0% in 4QFY2021.

Two of MUST’s top ten tenants by gross rental income (GRI) have lease expiries in 2023, with one tenant intending to vacate by December 2023. However, these leases have rents 9.9% below market rates, indicating possible positive rental reversion.

For more stories about where money flows, click here for Capital Section

They add: “Management has already started searching for possible tenants to take up the space after 2023, mitigating any loss in rental income.”

In a May 10 note, DBS Group Research analyst Rachel Tan maintains "buy" on MUST with a target price of 88 US cents.

"MUST is now placed on a better playing field post index inclusion in the FTSE EPRA Nareit Developed Asia Index where it will likely herald a virtuous cycle of greater investor visibility. Following this, we have already seen higher trading liquidity and yield compression for MUST. Given a strong execution and acquisition track record, we believe MUST will continue to command a premium to its peers," writes Tan.

In a May 10 note, RHB Group Research analyst Vijay Natarajan maintains "buy" with a lowered target price of 83 US cents from 86 cents previously.

Tripp Gantt takes over as new CEO with the retirement of Jill Smith, who was CEO since listing in 2016. Gantt, an American, has more than 23 years of experience in real estate including 16 years overseeing real estate companies on behalf of Washington State Investment Board, a US pension fund with US$25 billion in real estate.

Writes Natarajan: "He highlighted his key focus would be on improving MUST’s operational performance: boosting occupancy, income and valuation of assets. We believe his vast experience could bring in more M&A opportunities for the REIT in the medium term."

As at 11.04am, units in Manulife US REIT are trading 0.5 US cents lower, or 0.83% down, at 59.5 US cents.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.